SEC Form DEFA14A filed by Sotera Health Company
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
| ¨ | Preliminary Proxy Statement |
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ¨ | Definitive Proxy Statement |
| x | Definitive Additional Materials |
| ¨ | Soliciting Material Pursuant to § 240.14a-12 |
SOTERA HEALTH COMPANY
(Name of Registrant as Specified In Its Charter)
Payment of Filing Fee (Check all boxes that apply):
| x | No fee required. |
| ¨ | Fee paid previously with preliminary materials. |
| ¨ | Fee computed on table required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
Your Vote Counts! |
||||||||||||
|
|
SOTERA HEALTH COMPANY
2025 Annual Meeting of Stockholders Vote by May 20, 2025 11:59 PM ET
|
|||||||||||
|
SOTERA HEALTH COMPANY 9100 SOUTH HILLS BLVD, SUITE 300 BROADVIEW HEIGHTS, OH 44147 |
 |
|||||||||||
|
| ||||||||||||
| V68001-P25711 | ||||||||||||
You invested in SOTERA HEALTH COMPANY and it’s time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the Annual Meeting of Stockholders to be held on May 21, 2025.
Get informed before you vote
View the Notice and Proxy Statement, Annual Report and Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 7, 2025. If you would like to request a copy of the materials for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
| Smartphone users
|
|
Vote Virtually at the Meeting* May 21, 2025 9:00 a.m. Eastern Time | ||||
| Point your camera here and | ||||||
| vote without entering a | ||||||
| control number | ||||||
|
|
Virtually at: www.virtualshareholdermeeting.com/SHC2025 | |||||
*Please check the meeting materials for any special requirements for meeting attendance.
Vote at www.ProxyVote.com
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the
upcoming stockholder meeting. Please follow
the instructions on
the reverse side to vote on these important matters.
| Voting Items | Board Recommends | |||
| 1. |
Elect the three following Class II director nominees to serve until the 2028 Annual Meeting of Stockholders:
Director Nominees:
|
|||
| 1a. |
Ruoxi Chen |
 For | ||
| 1b. |
Karen A. Flynn |
| ||
| 1c. |
Ann R. Klee |
| ||
| 2. |
Approve, on an advisory basis, the compensation of our named executive officers. |
For | ||
| 3. |
Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. |
For | ||
|
| ||||
| Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. |
V68002-P25711